Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05924919 · ClinicalTrials.gov registry record · NA
The Effects of Passive Heat Therapy in Patients With Chronic Kidney Disease
A NA study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT05924919: Completed NA study, sponsored by Virginia Commonwealth University.
NCT05924919 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05924919, a NA study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The objective of this proposal is to investigate the acute effects of whole-body passive heat therapy using far-infrared technology on vascular function, exercise capacity, and renal function in CKD patients. The central hypothesis is that an acute bout of whole-body passive heat therapy will be well-tolerated and lead to acute improvements in large blood vessel (macrovascular) function, small blood vessel (microvascular) function, and exercise capacity without significantly altering markers of acute kidney injury.
Primary Outcome
Change in urinary NGAL
Interventions
- PROCEDURE Whole-body Passive Heat Therapy (HT)
- PROCEDURE Thermoneutral Control (CON)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2023-09-18 |
| Est. Completion | 2024-03-19 |
| Phase | NA |
What the finished NCT05924919 record still lists
NCT05924919 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Whole-body Passive Heat Therapy (HT) is the first listed.
NCT05924919 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05924919 about?
NCT05924919 is a clinical study titled "The Effects of Passive Heat Therapy in Patients With Chronic Kidney Disease". The objective of this proposal is to investigate the acute effects of whole-body passive heat therapy using far-infrared technology on vascular function, exercise capacity, and renal function in CKD patients. The central hypothesis is that an acute bout of whole-body passive heat therapy will be wel...
What is the current status of trial NCT05924919?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2023-09-18. Estimated completion is 2024-03-19.
What interventions are being tested in trial NCT05924919?
The interventions under investigation include: Whole-body Passive Heat Therapy (HT) (PROCEDURE), Thermoneutral Control (CON) (PROCEDURE).
Who is sponsoring clinical trial NCT05924919?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05924919's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI